Literature DB >> 33151746

Predictors of Clinical Outcomes After Hip Arthroscopy: 5-Year Follow-up Analysis of 1038 Patients.

Benjamin G Domb1,2,3, Sarah L Chen4, Cammille C Go5, Jacob Shapira1, Philip J Rosinsky1, Mitchell B Meghpara1,3, David R Maldonado1, Ajay C Lall1,2,3.   

Abstract

BACKGROUND: Although hip arthroscopy has been shown to have favorable results, there is a paucity of literature describing predictive factors of 5-year clinical outcomes.
PURPOSE: To identify predictive factors of midterm outcomes after hip arthroscopy in a cohort of 1038 patients whose outcomes at minimum 2-year follow-up were previously reported. In addition, to provide a comparison of short- and midterm predictive factors in outcome measures after hip arthroscopy. STUDY
DESIGN: Case-control study; Level of evidence, 3.
METHODS: Data were prospectively collected and retrospectively reviewed on all patients undergoing hip arthroscopy between February 2008 and June 2012. Patients were included if they had minimum 5-year follow-up on 2 patient-reported outcomes: Nonarthritic Hip Score (NAHS) and modified Harris Hip Score. Patients were excluded if they had any previous ipsilateral hip conditions. Using bivariate and multivariate analyses, we analyzed the effect of 36 pre- and intraoperative variables on the NAHS, modified Harris Hip Score, and conversion to total hip arthroplasty.
RESULTS: A total of 1038 patients met the inclusion criteria for the 2-year study, and 860 met our listed inclusion criteria for the 5-year study. The mean follow-up time was 62.0 months (range, 60.0-120.0 months). The bivariate analysis identified 10 variables (4 categorical and 6 continuous) that were predictive of 5-year postoperative NAHS. For the multivariate analysis, 7 variables were identified as being significant: preoperative NAHS, body mass index (BMI), age, lateral joint space, alpha angle, revision hip arthroscopy, and acetabular microfracture. These 7 variables were also predictive in the bivariate analysis. Age, BMI, revision hip arthroscopy, Tönnis grade, sex, trochanteric bursectomy, femoral head cartilage damage, and acetabular inclination were significant predictors of conversion to total hip arthroplasty.
CONCLUSION: This study reports favorable midterm clinical outcomes in the largest cohort of hip arthroscopies with minimum 5-year follow-up in the literature to date. Seven variables were identified as being significant predictors of postoperative NAHS in the bivariate and multivariate analyses: preoperative NAHS, BMI, age, lateral joint space, alpha angle, revision hip arthroscopy, and acetabular microfracture. Of these, preoperative NAHS, BMI, age, and revision hip arthroscopy were predictive of 2- and 5-year postoperative NAHS. These predictive factors may prove useful to clinicians in determining indications for hip arthroscopy and counseling patients on its expected outcomes.

Entities:  

Keywords:  Nonarthritic Hip Score; hip arthroscopy; midterm outcomes; predictive factors

Year:  2020        PMID: 33151746     DOI: 10.1177/0363546520968896

Source DB:  PubMed          Journal:  Am J Sports Med        ISSN: 0363-5465            Impact factor:   6.202


  9 in total

Review 1.  [Recent research progress of hip-preserving treatment for adolescents and adults with developmental dysplasia of the hip].

Authors:  Jinyan Wu; Xiaodong Chen
Journal:  Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi       Date:  2021-12-15

2.  Ultrasound Can Determine Joint Distraction During Hip Arthroscopy but Fluoroscopic-Guided Portal Placement Is Superior.

Authors:  Nicholas A Trasolini; Lakshmanan Sivasundaram; Morgan W Rice; Safa Gursoy; Ian M Clapp; Thomas D Alter; Stéfano Gaggiotti; Shane J Nho
Journal:  Arthrosc Sports Med Rehabil       Date:  2022-05-24

3.  Radiographic and Clinical Outcomes After Arthroscopic Microfracture for Osteochondral Lesions of the Talus: 5-Year Results in 355 Consecutive Ankles.

Authors:  Shaoling Fu; Kai Yang; Xueqian Li; Cheng Chen; Guohua Mei; Yan Su; Jianfeng Xue; Jian Zou; Jieyuan Zhang; Zhongmin Shi
Journal:  Orthop J Sports Med       Date:  2022-10-14

4.  Effect of Cigarette Smoking on Midterm Outcomes After Arthroscopic Surgery for Femoroacetabular Impingement Syndrome: A Propensity-Matched Controlled Study With Minimum 5-Year Follow-up.

Authors:  Andrew E Jimenez; Michael S Lee; Jade S Owens; David R Maldonado; Benjamin R Saks; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-05-10

5.  Outcomes and Return-to-Sport Rates for Elite Athletes With Femoral Retroversion Undergoing Hip Arthroscopy: A Propensity-Matched Analysis With Minimum 2-Year Follow-up.

Authors:  Jade S Owens; Andrew E Jimenez; Michael S Lee; David R Maldonado; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-06-03

6.  Sex-Based Differences in Athletes Undergoing Primary Hip Arthroscopy With Labral Reconstruction: A Propensity-Matched Analysis With Minimum 2-Year Follow-up.

Authors:  Jade S Owens; Michael S Lee; Andrew E Jimenez; David R Maldonado; Olivia A Paraschos; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-06-03

7.  Comparison of Outcomes Between Nonsmokers and Patients Who Discontinued Smoking 1 Month Before Primary Hip Arthroscopy: A Propensity-Matched Study With Minimum 2-Year Follow-up.

Authors:  Michael S Lee; Andrew E Jimenez; Jade S Owens; Andrew J Curley; Olivia A Paraschos; David R Maldonado; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-06-08

8.  Effect of Cigarette Smoking on Outcomes in Patients Undergoing Primary Hip Arthroscopy and Labral Reconstruction: A Propensity-Matched Controlled Study With Minimum 2-Year Follow-up.

Authors:  Andrew E Jimenez; Michael S Lee; Tom George; Jade S Owens; David R Maldonado; Benjamin R Saks; Ajay C Lall; Benjamin G Domb
Journal:  Orthop J Sports Med       Date:  2022-02-24

9.  Five-Year Follow-up After Hip Arthroscopic Surgery in the Horsens-Aarhus Femoroacetabular Impingement (HAFAI) Cohort.

Authors:  Signe Kierkegaard; Inger Mechlenburg; Ulrik Dalgas; Bent Lund
Journal:  Orthop J Sports Med       Date:  2022-03-08
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.